|Bid||130.610 x 800|
|Ask||130.710 x 1400|
|Day's Range||129.77 - 132.80|
|52 Week Range||118.62 - 148.99|
|Beta (3Y Monthly)||0.32|
|PE Ratio (TTM)||228.79|
|Earnings Date||Jan 22, 2019|
|Forward Dividend & Yield||3.60 (2.71%)|
|1y Target Est||148.56|
The consumer-health-care giant reaffirmed its full-year forecast of earnings per share of $8.13 to $8.18, on revenue of $81 billion to $81.4 billion. It also announced a $5 billion buyback plan.
Wall Street rose on Tuesday, helped by technology stocks, upbeat earnings reports and a rebound in few bellwether stocks, while investors awaited clues on the Federal Reserve's path for future rate hikes. Amazon.com Inc was the biggest boost to the S&P and the Nasdaq and helped lift consumer discretionary stocks .
The Dow Jones Industrial Average rose on Tuesday for the first time in three days after closing during the previous session at its lowest level since March 23. rose 3.9% after the aerospace giant lifted its dividend by 20% and increased the size of its stock buyback program by $2 billion to $20 billion. was rising 2.5% after the software company's fiscal second-quarter adjusted earnings and revenue topped analysts' forecasts.
Attorney Mark Lanier, who won a nearly $4.7 billion J&J talc verdict, says the recent stock plunge plays into his hands in seeking a settlement. J&J has lost roughly $50 billion in stock market value since Friday's Reuters report, alleging the company knew for decades about asbestos in baby powder. On CNBC, J&J Chairman and CEO Alex Gorsky defends the company against the Reuters report and the lawsuits like the one Lanier litigated.
"I miss the old days, the days when I when I would go home and listen to the Oracle (ORCL) conference call and think about what the impact would be for the stock market -- and the Nasdaq in particular," wrote Cramer in his Real Money column Tuesday, Dec. 18. TheStreet's Scott Rutt reported on Cramer's Mad Money show from Monday, Dec. 17. Shares of J&J plunged 10% on Friday after the story broke and another 2.9% today, wiping out over $50 billion in market cap.
Here are some of the companies with shares expected to trade actively in Tuesday’s session. Stock movements noted by ticker reflect movements during regular trading hours; premarket trading is specified separately.
J&J's (JNJ) board authorizes a $5-billion share repurchase plan. Stock slips 2.9% on Monday, extending a 10% drop on Friday post publication of a controversial Reuters story.
Wall Street was set to open higher on Tuesday, after a 2-percent fall in the prior session, boosted by some strong earnings and a bounce in certain bellwether stocks as investors wait for clues on the Federal Reserve's path for future rate hikes. While investors have baked in a fourth rate hike for the year on Wednesday, turbulence in the stock markets and a host of other worries have fueled calls, including from President Donald Trump, for the Fed to pause its tightening cycle or risk harming the U.S. economy. JPMorgan Chase & Co Citigroup Inc, Goldman Sachs Group Inc and Bank of America Corp rose about 1 percent.
Check out the companies making headlines before the bell: Darden Restaurants DRI – The restaurant chain earned 92 cents per share for its second quarter , a penny a share above estimates. Revenue was very slightly below Street forecasts, and a same-restaurant sales increase of 2.
One of the more cautious equity strategists alluded to this earlier in the week: Morgan Stanley’s Mike Wilson, in discussing the many signs investors were giving up on equities, found that as expectations for 2019 become more realistic, the groundwork may be "finally" setting up for rally. The action overnight may be just what Santa Claus needed to work up that rally bulls have been waiting for what seems like forever.
Johnson and Johnson is denying the explosive report from Reuters that the company knew there was asbestos in its baby powder. Yahoo Finance’s Alexis Christoforous speaks to Managing Partner & CEO Leon LaBrecque of LJPR Financial Advisors about the pressure the company is facing.
Mark Lanier, the attorney representing the 22 women and their families who won a lawsuit in July against Johnson & Johnson, joins 'Squawk Box' to discuss the Reuters report on the company's alleged knowledge about asbestos in its baby powder.